BioCentury
ARTICLE | Clinical News

Thymectacin: Phase I

November 25, 2002 8:00 AM UTC

Preliminary results from a U.S. Phase I trial in 24 patients with advanced colorectal cancer that failed standard chemotherapy showed Thymectacin was well tolerated at all dose levels from 200-2,000 ...